Raymond James Financial Services Advisors, Inc. Pds Biotechnology Corp Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Oct 24, 2023	BUY	$4.8 - $6.4 $53,539 - $71,385	11,154 New	11,154 $56,000
Q1 2023 Apr 14, 2023	BUY	$5.68 - $11.99 $147,214 - $310,756	25,918 New	25,918 $159,000

Others Institutions Holding PDSB

# of Institutions

Shares Held

4.05M

Call Options Held

253K

Put Options Held

70.4K

Vanguard Group Inc Valley Forge, PA

1.52M
Shares

$2.3 Million
0.0% of portfolio
Black Rock Inc. New York, NY

487K
Shares

$735,320
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

415K
Shares

$626,820
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

234K
Shares

$353,655
0.0% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

134K
Shares

$202,732
0.0% of portfolio

View Full List

About PDS Biotechnology Corp

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $43M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

More about PDSB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account